GENE THERAPY:
Second Child in French Trial Is Found to Have Leukemia
Eliot Marshall
For the second time in 4 months, a child has
developed a leukemia-like disease after receiving gene therapy at
the Necker Hospital for Sick Children in Paris. Concerned about
the safety of such trials, the panel that monitors U.S. research
in the field scheduled a public meeting this week to review the
clinical data and weigh its next steps.
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.
![[To top]](uparr_cc0000.gif){kind=small}
